Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:45 PM
Ignite Modification Date:
2025-12-24 @ 11:45 PM
NCT ID:
NCT05936151
Eligibility Criteria:
Inclusion Criteria:
* Have a body mass index (BMI) ≥27 kilogram/square meter (kg/m²)
* Have either
* no T2D with an HbA1c \< 6.5% or
* have T2D with an HbA1c ≤ 9.5% and treated with diet and exercise only or with stable doses of up to 3 oral antihyperglycemic medications, with or without basal insulin for at least 90 days before screening.
* Have been diagnosed with chronic kidney disease (CKD).
Exclusion Criteria:
* Have a self-reported change in body weight \>5 kilogram (kg) (11 pounds) within 90 days before screening.
* Have used in 90 days before the screening any of the following antihyperglycemic class: Dipeptidyl Peptidase IV (DPP4) inhibitors, amylin analogs, glucagon-like peptide-RA (GLP-RA), gastric inhibitory polypeptide (GIP)/GIP-1 RA, and short acting or rapid acting insulins or U500 Insulin
* Have a prior or planned surgical treatment for obesity
* Have Type 1 Diabetes (T1D)
* Have acute or chronic hepatitis
* Have a history of malignant disease within 5 years before screening.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT05936151
Study Brief:
Protocol Section:
NCT05936151